-
Oracle NetSuite Recognized as a Leader in Gartner Magic Quadrant Reports
Oracle NetSuite has been recognized as a Leader in Gartner’s 2025 Magic Quadrant reports for Cloud ERP
-
Digital Transformation with AI-Powered Oracle NetSuite ERP
Digital Transformation is most successful when technology, data, and industry expertise come together. As a
-
How Oracle NetSuite ERP Is Powering a New Era of Resilience in Big Health
The Shift Toward Data-Driven Healthcare Resilience Healthcare organizations face rising complexity — fluctuating reimbursements, staffing
-
How AI Is Transforming ERP Systems
Artificial Intelligence (AI) is no longer just a buzzword in the enterprise technology landscape—it’s a
-
Unlock Greater Efficiency in Attendance, Meeting Management & Guest Handling
As a valued Vantis HR customer, you’ve already experienced the power of digital transformation in
-
Inventory Visibility. Supply Chain Stability – Oracle NetSuite Keeps Your Operations Running Smoothly
Are inventory errors or supply chain delays impacting your delivery schedules and profit margins? Oracle
-
庫存透明．供應穩定 – Oracle NetSuite 助您營運無斷點
您是否因庫存錯誤或供應鏈延遲而影響交期與利潤？Oracle NetSuite ERP 為批發與分銷業量身打造雲端解決方案，協助您： 已有超過 41,000 家企業選擇 Oracle NetSuite，成功提升營運效率與庫存準確率。現在就啟動您的數位轉型！
-
Vantis特製生物科技行業Add-on，助企業迎合香港醫管局現代化改革
專為生物科技/制藥行業而設計的Oracle NetSuite ERP方案，提供了一系列功能和優勢，助您提高業務效率、降低成本並實現更好的效果。 我們透過為眾多生物科技和藥業行業客戶實施Oracle NetSuite ERP所累積的經驗，十分了解香港醫管局對行業的嚴格監管。有見及此，我們建立了一套專為生物科技和藥業行業而設的Add-on，以迎合香港醫管局HKHA現代化改革，功能包括： 藥品產品屬性模板 (Pharmaceutical Product Attributes Template) 特點：我們依據行業嚴格的法規和合規要求，設計出一個藥品產品屬性模板。用家於Oracle NetSuite可以保存以下資料：保存期限、產品成分、製造商資訊、批次管理、產品證書/許可證、產品毒性分類和原產地國家等等，以迎合香港醫管局現代化改革。 EzTrade 與Oracle
-
Vantis’ Custom Biotech Industry Add-on to Support Enterprises in Meeting HKHA Modernization Reforms
繁體 Specifically designed for the biotechnology and pharmaceutical industries, the Oracle NetSuite ERP solution provides
-
Connecting Dollors to Outcomes in Nonprofits NGO
How do nonprofits measure impact when attempting to solve complicated issues that are influenced by
